SYMPTOMATIC PARKINSON DISEASE
Clinical trials for SYMPTOMATIC PARKINSON DISEASE explained in plain language.
Never miss a new study
Get alerted when new SYMPTOMATIC PARKINSON DISEASE trials appear
Sign up with your email to follow new studies for SYMPTOMATIC PARKINSON DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood pressure drug shows promise in slowing Parkinson's progression
Disease control OngoingThis study looks at whether terazosin, a drug usually used for high blood pressure, can slow the progression of Parkinson's disease. Researchers are tracking changes in heart and brain scans of 15 people who are either in early stages or at high risk for Parkinson's. The goal is …
Matched conditions: SYMPTOMATIC PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a common heart pill slow Parkinson's? small trial aims to find out
Disease control OngoingThis phase 2 trial tests whether carvedilol, a drug usually used for heart conditions, can slow the loss of dopamine transporters in the brain and delay Parkinson's symptoms. It follows 15 people with REM sleep behavior disorder and other early Parkinson's risk factors over three…
Matched conditions: SYMPTOMATIC PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a common heart pill delay Parkinson's? small study hints at possibility
Knowledge-focused OngoingThis study looks at whether carvedilol, a drug used for heart failure, can reverse early heart changes seen in people with a sleep disorder that puts them at high risk for Parkinson's disease. Fifteen participants with REM sleep behavior disorder or reduced sense of smell will ta…
Matched conditions: SYMPTOMATIC PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Michele Tagliati, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Can a common drug reveal Parkinson's before symptoms start?
Knowledge-focused OngoingThis study looks at whether terazosin, a drug used for high blood pressure, can change heart nerve activity in people at high risk for Parkinson's disease. Researchers are studying 15 adults with REM sleep behavior disorder (a strong early sign of Parkinson's) to see if the drug …
Matched conditions: SYMPTOMATIC PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC